Meeting
2022 ASCO Annual Meeting
Prostate-specific membrane antigen expression in meningioma.
Authors
Heinrich Elinzano
Rhode Island Hospital, Providence, RI
Heinrich Elinzano , Teddi Tubre , Sean Hacking , Abigail Alexander , Arlen Brickman , Ivana Delalle , John Donahue
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Non-Glioma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2072)
DOI
10.1200/JCO.2022.40.16_suppl.2072
Abstract #
2072
Poster Bd #
410
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.
First Author: Philip Sutera
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA-based PET as an imaging biomarker of androgen receptor signaling in high-risk localized and locally advanced prostate cancer (PCa).
First Author: Keara English
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.
First Author: Richard Bennett IV
Poster
2023 ASCO Annual Meeting
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
First Author: Emeline Tabouret